Martin Fisher Foundation: 14 September 2015 www.i-Base.info Remembering Martin Fisher Simon Collins, HIV i-Base Who should get tested? How and why should.

Slides:



Advertisements
Similar presentations
Impact of Age and Race on New HIV Infections among Men who have Sex with Men in Los Angeles County Shoshanna Nakelsky, MPH Division of HIV and.
Advertisements

Treatment as prevention: cannot succeed without increased testing AND PRIMARY PREVENTION example from the United Kingdom? Dr Valerie Delpech Head of HIV.
Introduction PRO(TECT) is a partnership project between Terrence Higgins Trust and The Claude Nicol Clinic (CNC) GUM in Brighton. It provides a new tailor-made.
HIV in the United Kingdom: Setting the scene
Mortality and causes of death among women living with HIV in the UK in the era of highly-active antiretroviral therapy Sara Croxford, A Kitching, M Kall,
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
The hidden HIV epidemic: what do mathematical models tell us? The case of France Virginie Supervie, Jacques Ndawinz & Dominique Costagliola U943 Inserm.
Treatment as prevention (TASP) for HIV and HCV: The evidence and modelling Peter Vickerman.
HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.
TasP is not enough Stipulated that TasP is effective in reducing infectiousness of the treated person – But much more is required. TasP requires effective.
S Collins, HIV i-BaseUK CAB ACTIVIST TRAINING OCTOBER 2014 Science & research Simon Collins HIV i-Base i)why we need evidence and not just expert opinion.
Ecological Model for HIV Risk in MSM Stage of Epidemic Individual Community Public Policy Network Level of Risks Source: Baral and Beyrer, 2006.
Community HIV testing for men who have sex with men (MSM) Will it decrease undiagnosed infection? Jonathan Roberts Liaison Health Adviser Brighton & Sussex.
New York State Department of Health AIDS Institute June, 2014
Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention James Wilton Project.
Estimation of the number of people with undiagnosed HIV infection in a country Andrew Phillips, UCL, London HIV in Europe Meeting 2 November 2009, Stockholm.
Illustrating the HIV Care Continuum in U.S. Cities Philadelphia, PA.
Can we reach UNAIDS targets and will this lead to the elimination of HIV in the UK? Dr Valerie Delpech Head of national HIV surveillance.
Positive Living Navajo AIDS Network, Inc. Melvin Harrison, Executive Director Marco Arviso, Arizona Medical Case Manager.
Treatment as prevention: a new paradigm for HIV control? Richard Hayes.
START study: UK-CAB July2015 Community feedback: START study Simon Collins HIV i-Base
Management of the Newly Diagnosed Patient. Jane Bruton Clinical Research Nurse Imperial College.
S Collins, HIV i-BaseUK CAB ACTIVIST TRAINING OCTOBER 2013 Science & research Simon Collins HIV i-Base i)why we need evidence and not just expert opinion.
IAS 2012 feedback: UK Consortium: September 2012 IAS 2012 Feedback: New findings, better drugs and the goal of a cure Simon Collins HIV.
What do models estimate to be the impacts on HIV incidence of various percentages of people with HIV on ART ? National AIDS Trust Treatment as Prevention.
Embedding Open-label PrEP trial in expansion of UK HIV Prevention Programme.
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
Bloomsbury Clinic, May 2015 Simon Collins: Treatment update: generics Simon Collins i-Base.info.
Myron S. Cohen, MD Associate Vice Chancellor Director, Institute for Global Health The University of North Carolina.
Mr X and Mr Y 1 Case 4: July year-old Caucasian man ‘Mr X’ 2.
JORDAN E. LAKE, MD, MSC AAHU SEPTEMBER 2014 Prevention for Positives.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
NURSETRI, Nursing role in HIV care : an overview Jane Bruton Clinical Research Nurse.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
UNITED STATES CONFERENCE ON AIDS MONDAY, SEPTEMBER 9, 2013 NEW ORLEANS, LA Will Community Involvement in Test Link to Care, Plus Treat Research (HPTN 065)
S Collins, I-Base: HIV and cancerUK-CAB April 2013 Introduction to HIV and cancer Simon Collins HIV i-Base.
Immigration Removal Centres and HIV Clinical Care Jane Anderson Homerton University Hospital NHS Foundation Trust.
HIV-infected subjects with CD4 350 to 550 cells/mm serodiscordant couples HPTN 052 Study Design Immediate ART CD Delayed ART CD4
STATE OF THE STATE SHELLEY LUCAS HIV/STD PREVENTION & CARE BRANCH DEPT OF STATE HEALTH SERVICES AUGUST 3, 2015.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The United Kingdom provides excellent access and quality of.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System RITA as part of routine national HIV surveillance: Experience.
Providing Treatment, Restoring Hope Secondary Prevention as part of HIV Clinical Care Martine Etienne, MPH, DrPH University of Maryland School of Medicine.
Treatment as Prevention and Treatment 2.0 Update UN Forum on AIDS, 24 June 2011 Nicole Seguy, Zhang Lan, WHO.
Understanding temporal trends in HIV prevalence, incidence and ARV Dr Valerie Delpech Head of HIV surveillance Public Health England.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The threshold for an ART secondary prevention effect on HIV.
High-impact interventions. Number of people living with HIV who were not receiving antiretroviral therapy, 2014 and 2015 Source: UNAIDS estimates, 2014.
JORDAN E. LAKE, MD, MSC AAHU AUGUST 2015 Prevention for Positives.
HIV Testing in Medical Settings Mark Thrun, MD Denver Public Health
Social Context and the Health of Sex Workers in San Francisco Deborah Cohan, MD, MPH 1, Johanna Breyer, MSW 2, Cynthia Cobaugh 2, Charles Cloniger, NP,
Preventing HIV/AIDS transmission on Historically Black Colleges and Universities (HBCUs) Peter Thomas, PhD, MPH Division of HIV/AIDS Prevention, Division.
Mean HIV viral load among resident cases and undiagnosed in Oregon Jeff Capizzi, Epidemiologist Sean Schafer, HIV/STD/TB Medical Epidemiologist Lea Bush,
Allie Lyman.  Incidence and Prevalence  Risk Factors and Barriers to Prevention  Prevention  Conclusion.
Grinsztejn B, et al, Lancet Infect Dis, March 4 th 2014 PRIMARY COMBINED M&M OUTCOME FIRST AIDS DEFINING EVENT FIRST TB EVENT DEATH.
HIV, SEXUAL & REPRODUCTIVE HEALTH OF KEY POPULATIONS Module 3: Engaging Key Populations with HIV and SRH services.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System Predictors for high viraemia among the treatment naïve population.
Fast-Tracking Treatment to End AIDS ICASA Ambassador Deborah Birx, MD U.S. Global AIDS Coordinator November 30, 2015.
3 April 2003 Treatment as prevention: why? Gus Cairns Editor, HIV Treatment Update.
HIV Prevention: A Winnable Battle Centers for Disease Control and Prevention.
Expanded PrEP implementation across Australia Expanded implementation of PrEP across Australia 1.
Understanding HIV risk and transmission among migrants
HPTN 071 (PopART): Have we reached the targets after two years of the PopART intervention IAS Paris July 2017 Richard Hayes.
HIV self-testing: feasibility and acceptability of a large scale national service Cary James Head of Health Improvement Programmes Terrence Higgins Trust,
Entry into care Failure to initiate timely HIV care after diagnosis is common ~75% of newly diagnosed link to care within 6-12 months Delayed entry into.
Richard hayes London school of hygiene & Tropical Medicine
John de Wit1,2, Dean Murphy2,3, Luxi Lal4,5,6, Jennifer Audsley5,7, Christopher K. Fairley8,9, Mark Stoove4,10, Norm Roth11, Richard Moore12, Ban K.
Chloe Orkin British HIV Association Queen Mary University London
WORLD AIDS DAY 2018 HIV in the UK
An Update from CROI and the Changing Landscape of HIV in NZ
WORLD AIDS DAY 2018 HIV in the UK
Dismas Gashobotse, MD FHI 360/LINKAGES, Burundi
Presentation transcript:

Martin Fisher Foundation: 14 September Remembering Martin Fisher Simon Collins, HIV i-Base Who should get tested? How and why should I get tested?

Martin Fisher Foundation: 14 September Remembering Martin Fisher

Martin Fisher Foundation: 14 September Overview Background: gay men in the UK Who should test? How to test? Where to test? Conclusions

Martin Fisher Foundation: 14 September Annual diagnoses in gay men Year UK national data, 2014 Number of diagnoses ~3000 gay men diagnosed every year for the last 10 years

Martin Fisher Foundation: 14 September Annual diagnoses in gay men Year UK national data, 2014 Number of diagnoses ~2800 gay men infected every year for the last 10 years ~3000 gay men diagnosed every year for the last 10 years

Martin Fisher Foundation: 14 September Country of HIV infection: gay men PHE, HIV in the UK, 2014 Number of diagnoses Likely infection in the UK Likely infection outside the UK

Martin Fisher Foundation: 14 September Context of ART Reduced risk when viral load <50 c/mL. Zero linked transmissions in PARTNER after 44,500 times without a condom. [1] Zero linked transmissions over 4 years in HPTN-052. [2] 1. Rodger A et al. CROI Cohen M et al, IAS 2015.

Martin Fisher Foundation: 14 September UK cascade is remarkable 95% in care, 90% on ART, 90% <50 c/mL. [1] Likely to increase with earlier ART. [2] START: 98% <50 c/mL - with efavirenz. [3] 1. UK PHE 2014; 2. BHIVA draft guidelines, June 2015; 3. Lundgren J et al, START study, NEJM 2015.

Martin Fisher Foundation: 14 September Gay men: who to test? 8,000 gay men are not yet diagnosed: “This could be you”. Differences by age and experience – school, peer pressure, Grindr, drugs as a norm, perceived low risk, bad luck. Frequent vs within 1- 5 years vs never.

Martin Fisher Foundation: 14 September Gay men: who to test in 2015? Frequent testers engaged in care - need option of PrEP - £30 per month. Infrequent testers (270,000) need testing to be easier: self sampling and testing? Never tested: denial? Needle-phobic?

Martin Fisher Foundation: 14 September Gay men: how to test? Routine part of sexual health. Opt-out? STI clinic vs community venues. Frequent testers need 4 th gen; other can use 3 rd or 4 th gen: option by post. Rapid testing vs result? Pantheon study – NIHR funded study.

Martin Fisher Foundation: 14 September Making testing easier Clinics: easy access, no appointment. Clean, friendly, modern. Non-judgemental services. Free/cheap, rapid results. Rapid treatment and care – for HIV and STIs.

Martin Fisher Foundation: 14 September Why test? For personal and community reasons. No one expects to be HIV+. 30% gay men still test late (CD4 <350) ART is now universally available: better health and reduced risk to partners. Why not?

Martin Fisher Foundation: 14 September % 64% 79% base test rate ART at diagnosis test rate + 215,000 tests test rate ,000 tests Current testing at 110,000pa and ART at 350 Rapid impact on UK incidence from increased testing by gay men Number of new infections a year Adapted from: Phillips AN et al. AIDS June 2015.

Martin Fisher Foundation: 14 September % 64% 79% base test rate ART at diagnosis test rate + 215,000 tests test rate ,000 tests Current testing at 110,000pa and ART at 350 Rapid impact on UK incidence from increased testing by gay men Number of new infections a year Adapted from: Phillips AN et al. AIDS June 2015.

Martin Fisher Foundation: 14 September Conclusions New landscape – even with NHS problems. Earlier, better, wider use of ART. Prevention has ART, PrEP, better testing. Increased diagnoses reduces infection rate. Window of chance – depends on setting incidence targets: 3000 >2000 >1000 >0.

Martin Fisher Foundation: 14 September Community testing Evaluate outcome by new diagnoses not the number of tests.

Martin Fisher Foundation: 14 September Community testing … he does not know!

Martin Fisher Foundation: 14 September Community testing “2016: YEAR of HIV TESTING” branded by all organisations: public and community PHE, THT, GMFA etc

Martin Fisher Foundation: 14 September Thanks Andrew Phillips Valerie Delpeche Robert James And to Martin Fisher for so many years of support and encouragement.